Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Precigen, Inc. (PGEN) Institutional Ownership & Insider Trading

211 institutions reported holding Precigen, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 41 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

PGENPrecigen, Inc.Follow PGEN — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
2.2B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
11 Nov, in 18 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

211 institutions held 39.2% of the shares. Across filers that reported both quarters, shares held changed +5.1%.

Increased+81New+33Decreased-44Closed-24

Largest moves, shares (millions)

Diametric Capital+2.5MFirst Trust Advisors+2.0MBlackRock+1.9MPoint72 Asset Management-5.4MCitadel Advisors-1.9MJane Street Group-1.8M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+14.1Sep 24-0.2Dec 24+4.6Mar 25+1.5Jun 25+26.9Sep 25+28.3Dec 25-4.9Mar 26+6.8Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 26211140+5.1%81334424
Mar 26204134-3.9%55364315
Dec 25176136+28.6%72263217
Sep 25163112+32.6%47323714
Jun 2514582+1.9%3922299
Mar 2513480+6.2%28193814
Dec 2412976-0.3%39172318
Sep 2412775+27.8%35112915

Precigen, Inc. — questions

Who owns Precigen, Inc. stock?
211 institutions reported Precigen, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Patient Capital Management, LLC (5.3%), BlackRock, Inc. (4.8%), STATE STREET CORP (3.4%).
Are Precigen, Inc. insiders buying or selling?
41 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Precigen, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.